Pharmaceuticals Ultrasector Profund Fund Probability of Future Mutual Fund Price Finishing Under 26.12
| PHPIX Fund | USD 27.85 0.48 1.75% |
Pharmaceuticals |
Pharmaceuticals Ultrasector Target Price Odds to finish below 26.12
The tendency of Pharmaceuticals Mutual Fund price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 26.12 or more in 90 days |
| 27.85 | 90 days | 26.12 | about 18.6 |
Based on a normal probability distribution, the odds of Pharmaceuticals Ultrasector to drop to $ 26.12 or more in 90 days from now is about 18.6 (This Pharmaceuticals Ultrasector Profund probability density function shows the probability of Pharmaceuticals Mutual Fund to fall within a particular range of prices over 90 days) . Probability of Pharmaceuticals Ultrasector price to stay between $ 26.12 and its current price of $27.85 at the end of the 90-day period is about 54.83 .
Assuming the 90 days horizon the mutual fund has the beta coefficient of 1.3 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pharmaceuticals Ultrasector will likely underperform. Additionally Pharmaceuticals Ultrasector Profund has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Pharmaceuticals Ultrasector Price Density |
| Price |
Predictive Modules for Pharmaceuticals Ultrasector
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmaceuticals Ultrasector. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pharmaceuticals Ultrasector Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmaceuticals Ultrasector is not an exception. The market had few large corrections towards the Pharmaceuticals Ultrasector's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmaceuticals Ultrasector Profund, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmaceuticals Ultrasector within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 1.30 | |
σ | Overall volatility | 1.14 | |
Ir | Information ratio | -0.02 |
Pharmaceuticals Ultrasector Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmaceuticals Ultrasector for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmaceuticals Ultrasector can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Latest headline from news.google.com: Franklin Gold And Precious Metals Fund Q3 2024 Commentary - Seeking Alpha | |
| The fund generated three year return of -1.0% | |
| Pharmaceuticals Ultrasector maintains about 19.93% of its assets in cash |
Pharmaceuticals Ultrasector Technical Analysis
Pharmaceuticals Ultrasector's future price can be derived by breaking down and analyzing its technical indicators over time. Pharmaceuticals Mutual Fund technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharmaceuticals Ultrasector Profund. In general, you should focus on analyzing Pharmaceuticals Mutual Fund price patterns and their correlations with different microeconomic environments and drivers.
Pharmaceuticals Ultrasector Predictive Forecast Models
Pharmaceuticals Ultrasector's time-series forecasting models is one of many Pharmaceuticals Ultrasector's mutual fund analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharmaceuticals Ultrasector's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the mutual fund market movement and maximize returns from investment trading.
Things to note about Pharmaceuticals Ultrasector
Checking the ongoing alerts about Pharmaceuticals Ultrasector for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharmaceuticals Ultrasector help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Latest headline from news.google.com: Franklin Gold And Precious Metals Fund Q3 2024 Commentary - Seeking Alpha | |
| The fund generated three year return of -1.0% | |
| Pharmaceuticals Ultrasector maintains about 19.93% of its assets in cash |
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |